vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.

READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $41.9M, roughly 1.2× ARVINAS, INC.). READING INTERNATIONAL INC runs the higher net margin — -5.1% vs -83.8%, a 78.7% gap on every dollar of revenue. On growth, READING INTERNATIONAL INC posted the faster year-over-year revenue change (-14.2% vs -59.1%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $-59.2M). Over the past eight quarters, ARVINAS, INC.'s revenue compounded faster (10.0% CAGR vs 5.6%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.

ARVN vs RDI — Head-to-Head

Bigger by revenue
RDI
RDI
1.2× larger
RDI
$50.3M
$41.9M
ARVN
Growing faster (revenue YoY)
RDI
RDI
+44.9% gap
RDI
-14.2%
-59.1%
ARVN
Higher net margin
RDI
RDI
78.7% more per $
RDI
-5.1%
-83.8%
ARVN
More free cash flow
RDI
RDI
$63.3M more FCF
RDI
$4.1M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
ARVN
ARVN
Annualised
ARVN
10.0%
5.6%
RDI

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
RDI
RDI
Revenue
$41.9M
$50.3M
Net Profit
$-35.1M
$-2.6M
Gross Margin
Operating Margin
-104.5%
-1.9%
Net Margin
-83.8%
-5.1%
Revenue YoY
-59.1%
-14.2%
Net Profit YoY
28.7%
-14.5%
EPS (diluted)
$-0.48
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
RDI
RDI
Q4 25
$50.3M
Q3 25
$41.9M
$52.2M
Q2 25
$60.4M
Q1 25
$188.8M
$40.2M
Q4 24
$59.2M
$58.6M
Q3 24
$102.4M
$60.1M
Q2 24
$76.5M
$46.8M
Q1 24
$25.3M
$45.1M
Net Profit
ARVN
ARVN
RDI
RDI
Q4 25
$-2.6M
Q3 25
$-35.1M
$-4.2M
Q2 25
$-2.7M
Q1 25
$82.9M
$-4.8M
Q4 24
$-45.1M
$-2.2M
Q3 24
$-49.2M
$-7.0M
Q2 24
$-35.2M
$-12.8M
Q1 24
$-69.4M
$-13.2M
Operating Margin
ARVN
ARVN
RDI
RDI
Q4 25
-1.9%
Q3 25
-104.5%
-0.6%
Q2 25
4.8%
Q1 25
37.8%
-17.2%
Q4 24
-98.1%
2.6%
Q3 24
-58.9%
-0.6%
Q2 24
-63.4%
-16.4%
Q1 24
-329.2%
-16.7%
Net Margin
ARVN
ARVN
RDI
RDI
Q4 25
-5.1%
Q3 25
-83.8%
-8.0%
Q2 25
-4.4%
Q1 25
43.9%
-11.8%
Q4 24
-76.2%
-3.8%
Q3 24
-48.0%
-11.7%
Q2 24
-46.0%
-27.4%
Q1 24
-274.3%
-29.4%
EPS (diluted)
ARVN
ARVN
RDI
RDI
Q4 25
$-0.11
Q3 25
$-0.48
$-0.18
Q2 25
$-0.12
Q1 25
$1.14
$-0.21
Q4 24
$-0.63
$-0.11
Q3 24
$-0.68
$-0.31
Q2 24
$-0.49
$-0.57
Q1 24
$-0.97
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
RDI
RDI
Cash + ST InvestmentsLiquidity on hand
$787.6M
$10.5M
Total DebtLower is stronger
$600.0K
$185.1M
Stockholders' EquityBook value
$564.4M
$-18.2M
Total Assets
$844.3M
$434.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
RDI
RDI
Q4 25
$10.5M
Q3 25
$787.6M
$8.1M
Q2 25
$9.1M
Q1 25
$954.3M
$5.9M
Q4 24
$1.0B
$12.4M
Q3 24
$1.1B
$10.1M
Q2 24
$1.2B
$9.3M
Q1 24
$1.2B
$7.5M
Total Debt
ARVN
ARVN
RDI
RDI
Q4 25
$185.1M
Q3 25
$600.0K
Q2 25
Q1 25
$700.0K
Q4 24
$800.0K
$202.7M
Q3 24
$800.0K
Q2 24
$900.0K
Q1 24
$900.0K
Stockholders' Equity
ARVN
ARVN
RDI
RDI
Q4 25
$-18.2M
Q3 25
$564.4M
$-12.1M
Q2 25
$-7.7M
Q1 25
$660.1M
$-8.1M
Q4 24
$561.7M
$-4.4M
Q3 24
$586.0M
$1.6M
Q2 24
$600.2M
$6.5M
Q1 24
$609.7M
$18.0M
Total Assets
ARVN
ARVN
RDI
RDI
Q4 25
$434.9M
Q3 25
$844.3M
$435.2M
Q2 25
$438.1M
Q1 25
$1.0B
$441.0M
Q4 24
$1.1B
$471.0M
Q3 24
$1.2B
$495.7M
Q2 24
$1.3B
$494.9M
Q1 24
$1.2B
$494.9M
Debt / Equity
ARVN
ARVN
RDI
RDI
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
RDI
RDI
Operating Cash FlowLast quarter
$-59.1M
$4.3M
Free Cash FlowOCF − Capex
$-59.2M
$4.1M
FCF MarginFCF / Revenue
-141.3%
8.2%
Capex IntensityCapex / Revenue
0.2%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$-2.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
RDI
RDI
Q4 25
$4.3M
Q3 25
$-59.1M
$295.0K
Q2 25
$1.6M
Q1 25
$-88.9M
$-7.7M
Q4 24
$-84.1M
$8.0M
Q3 24
$-128.0M
$1.3M
Q2 24
$50.3M
$-10.4M
Q1 24
$-97.5M
$-2.8M
Free Cash Flow
ARVN
ARVN
RDI
RDI
Q4 25
$4.1M
Q3 25
$-59.2M
$-246.0K
Q2 25
$1.2M
Q1 25
$-89.3M
$-8.0M
Q4 24
$-84.4M
$7.0M
Q3 24
$-128.7M
$-1.1M
Q2 24
$49.6M
$-10.6M
Q1 24
$-97.6M
$-4.7M
FCF Margin
ARVN
ARVN
RDI
RDI
Q4 25
8.2%
Q3 25
-141.3%
-0.5%
Q2 25
1.9%
Q1 25
-47.3%
-19.8%
Q4 24
-142.6%
12.0%
Q3 24
-125.7%
-1.8%
Q2 24
64.8%
-22.7%
Q1 24
-385.8%
-10.4%
Capex Intensity
ARVN
ARVN
RDI
RDI
Q4 25
0.3%
Q3 25
0.2%
1.0%
Q2 25
0.6%
Q1 25
0.2%
0.6%
Q4 24
0.5%
1.7%
Q3 24
0.7%
4.0%
Q2 24
0.9%
0.5%
Q1 24
0.4%
4.3%
Cash Conversion
ARVN
ARVN
RDI
RDI
Q4 25
Q3 25
Q2 25
Q1 25
-1.07×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARVN
ARVN

Segment breakdown not available.

RDI
RDI

Cinema Exhibition Segment$46.9M93%
Real Estate Revenue$3.4M7%

Related Comparisons